News & Events

Home | News | Zeno Pathology obtained IVD CE-mark

Zeno Pathology obtained IVD CE-mark

WSK Medical, a company developing Artificial Intelligence (AI) solutions for (early) cancer detection, has received the IVD CE mark for their AI digital pathology solution called Zeno Pathology.

Zeno Pathology considerably reduces observer variability and manual analysis time whilst increasing the speed, consistency, and accuracy to analyse H&E and IHC stained breast cancer whole slide images. Zeno Pathology has the flexibility of being integrated in the existing digital workflow and is co-developed with the Computational Pathology lab at the Netherlands Cancer Institute.

If you want more information about Zeno Pathology, please contact us

Share –

Related articles

Towards Better Health & Care – The Potential of AI – 24th of May in Amsterdam

European Congress on Digital Pathology (ECDP) – 15th-18th of June in Berlin

Zeno Pathology available in Founda Health platform

Demo //

Book a demo

Want to learn more about our solutions?

Our website only uses essential cookies. These cookies are used to make the website function properly. By continuing your visit on our website, you understand this. All our privacy related matters can be found in our privacy policy.